Department of Anesthesiology, Columbia University, New York, New York 10032-3784, USA.
Kidney Int. 2012 Oct;82(8):878-91. doi: 10.1038/ki.2012.224. Epub 2012 Jun 13.
Renal ischemia-reperfusion injury is a major cause of acute kidney injury. We previously found that renal A(1) adenosine receptor (A(1)AR) activation attenuated multiple cell death pathways including necrosis, apoptosis, and inflammation. Here, we tested whether induction of cytoprotective sphingosine kinase (SK)-1 and sphingosine-1-phosphate (S1P) synthesis might be the mechanism of protection. A selective A(1)AR agonist (CCPA) increased the synthesis of S1P and selectively induced SK1 in mouse kidney and HK-2 cells. This agonist failed to protect SK1-knockout but protected SK2-knockout mice against renal ischemia-reperfusion injury indicating a critical role of SK1 in A(1)AR-mediated renal protection. Inhibition of SK prevented A(1)AR-mediated defense against necrosis and apoptosis in HK-2 cells. A selective S1P(1)R antagonist (W146) and global in vivo gene knockdown of S1P(1)Rs with small interfering RNA completely abolished the renal protection provided by CCPA. Mice selectively deficient in renal proximal tubule S1P(1)Rs (S1P(1)R(f)(/)(f) PEPCK(Cre/-)) were not protected against renal ischemia-reperfusion injury by CCPA. Mechanistically, CCPA increased nuclear translocation of hypoxia-inducible factor-1α in HK-2 cells and selective hypoxia-inducible factor-1α inhibition blocked A(1)AR-mediated induction of SK1. Thus, proximal tubule SK1 has a critical role in A(1)AR-mediated protection against renal ischemia-reperfusion injury.
肾缺血再灌注损伤是急性肾损伤的主要原因。我们之前发现,肾 A1 腺苷受体 (A1AR) 的激活减轻了多种细胞死亡途径,包括坏死、凋亡和炎症。在这里,我们测试了诱导保护性鞘氨醇激酶 (SK)-1 和鞘氨醇-1-磷酸 (S1P) 合成是否是保护的机制。选择性 A1AR 激动剂 (CCPA) 增加了 S1P 的合成,并在小鼠肾脏和 HK-2 细胞中选择性诱导 SK1。该激动剂不能保护 SK1 敲除小鼠,但能保护 SK2 敲除小鼠免受肾缺血再灌注损伤,表明 SK1 在 A1AR 介导的肾保护中起关键作用。SK 的抑制阻止了 A1AR 介导的对 HK-2 细胞坏死和凋亡的防御。选择性 S1P1R 拮抗剂 (W146) 和体内小干扰 RNA 敲低所有 S1P1Rs 完全消除了 CCPA 提供的肾保护。选择性缺乏肾近端小管 S1P1Rs 的小鼠 (S1P1R(f)(/)(f)PEPCK(Cre/-)) 不受 CCPA 对肾缺血再灌注损伤的保护。在机制上,CCPA 增加了 HK-2 细胞中缺氧诱导因子-1α 的核易位,而选择性缺氧诱导因子-1α 抑制阻断了 A1AR 介导的 SK1 诱导。因此,近端肾小管 SK1 在 A1AR 介导的肾缺血再灌注损伤保护中起着关键作用。